Management of hypertension and cerebrovascular disease in the elderly.

[1]  Li-sheng Liu,et al.  Treatment of hypertension in patients 80 years of age or older. , 2008, The New England journal of medicine.

[2]  F. Messerli,et al.  Does a change in angiotensin II formation caused by antihypertensive drugs affect the risk of stroke?: A meta-analysis of trials according to treatment with potentially different effects on angiotensin II , 2007, Journal of hypertension.

[3]  T. Turan,et al.  Relationship Between Blood Pressure and Stroke Recurrence in Patients With Intracranial Arterial Stenosis , 2007, Circulation.

[4]  L. Kalra,et al.  The effects of blood pressure reduction on cognitive function: a review of effects based on pooled data from clinical trials , 2006, Journal of hypertension.

[5]  Kazuomi Kario,et al.  Morning Hypertension: The Strongest Independent Risk Factor for Stroke in Elderly Hypertensive Patients , 2006, Hypertension Research.

[6]  S. Goldstein.  Cardiac Remodeling: Mechanism and Treatment , 2006 .

[7]  B. Dahlöf,et al.  Prospects for the prevention of stroke , 2006, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[8]  M. Ibrahim,et al.  RAS inhibition in hypertension , 2006, Journal of Human Hypertension.

[9]  G. Román.  Vascular Dementia Prevention: A Risk Factor Analysis , 2005, Cerebrovascular Diseases.

[10]  F. Messerli,et al.  The renin-angiotensin systems: evolving pharmacological perspectives for cerebroprotection. , 2005, Current pharmaceutical design.

[11]  M. Woodward,et al.  Effects of Blood Pressure Lowering on Cerebral White Matter Hyperintensities in Patients With Stroke: The PROGRESS (Perindopril Protection Against Recurrent Stroke Study) Magnetic Resonance Imaging Substudy , 2005, Circulation.

[12]  O. Anson,et al.  Hypertension and cognitive functioning among the elderly: an overview. , 2005, American journal of therapeutics.

[13]  A. Algra,et al.  Long-term survival and vascular event risk after transient ischaemic attack or minor ischaemic stroke: a cohort study , 2005, The Lancet.

[14]  H. Diener,et al.  Morbidity and Mortality After Stroke, Eprosartan Compared With Nitrendipine for Secondary Prevention: Principal Results of a Prospective Randomized Controlled Study (MOSES) , 2005, Stroke.

[15]  T. Ogihara,et al.  The Japanese Trial to Assess Optimal Systolic Blood Pressure in Elderly Hypertensive Patients (JATOS): Protocol, Patient Characteristics, and Blood Pressure during the First 12 Months , 2005, Hypertension Research.

[16]  P. Sleight.  The ONTARGET/TRANSCEND Trial Programme: baseline data , 2005, Acta Diabetologica.

[17]  J. Broderick,et al.  Incidence and Short-Term Prognosis of Transient Ischemic Attack in a Population-Based Study , 2005, Stroke.

[18]  G. Berglund,et al.  Blood Pressure Control and Risk of Stroke: A Population-Based Prospective Cohort Study , 2005, Stroke.

[19]  C. Bulpitt,et al.  CHHIPS (Controlling Hypertension and Hypotension Immediately Post-Stroke) Pilot Trial: rationale and design. , 2005, Journal of hypertension.

[20]  J. Schwartz,et al.  Short- and Long-Term Incidence of Stroke in White-Coat Hypertension , 2005, Hypertension.

[21]  H. Black.  The paradigm has shifted to systolic blood pressure , 2004, Journal of Human Hypertension.

[22]  Carole Dufouil,et al.  The Association Between Blood Pressure, Hypertension, and Cerebral White Matter Lesions: Cardiovascular Determinants of Dementia Study , 2004, Hypertension.

[23]  A. Hofman,et al.  Stroke prevention with the angiotensin II type 1-receptor blocker candesartan in elderly patients with isolated systolic hypertension: the Study on Cognition and Prognosis in the Elderly (SCOPE). , 2004, Journal of the American College of Cardiology.

[24]  G. Román.  Brain hypoperfusion: a critical factor in vascular dementia , 2004, Neurological research.

[25]  F. Messerli,et al.  Cerebroprotection mediated by angiotensin II: a hypothesis supported by recent randomized clinical trials. , 2004, Journal of the American College of Cardiology.

[26]  C. Iadecola,et al.  Hypertension, Angiotensin, and Stroke: Beyond Blood Pressure , 2004, Stroke.

[27]  L. Goldstein.  Blood pressure management in patients with acute ischemic stroke. , 2004, Hypertension.

[28]  T. Hedner,et al.  Cardiovascular events in elderly patients with isolated systolic hypertension. A subgroup analysis of treatment strategies in STOP‐Hypertension‐2 , 2004, Blood pressure.

[29]  C B Hall,et al.  Low blood pressure and the risk of dementia in very old individuals , 2003, Neurology.

[30]  Daniel W. Jones,et al.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. , 2003, Hypertension.

[31]  A. Hofman,et al.  The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial , 2003, Journal of hypertension.

[32]  A. Hofman,et al.  Silent brain infarcts and the risk of dementia and cognitive decline. , 2003, The New England journal of medicine.

[33]  B. Winblad,et al.  Low blood pressure and risk of dementia in the Kungsholmen project: a 6-year follow-up study. , 2003, Archives of neurology.

[34]  R. Collins,et al.  Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies , 2002, The Lancet.

[35]  H. Chui,et al.  Subcortical ischaemic vascular dementia , 2002, The Lancet Neurology.

[36]  M. Nieminen,et al.  Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy: a Losartan Intervention for Endpoint Reduction (LIFE) substudy. , 2002, JAMA.

[37]  M. Szklo,et al.  The relationship between temporal changes in blood pressure and changes in cognitive function: atherosclerosis risk in communities (ARIC) study. , 2002, Preventive medicine.

[38]  T. Unger,et al.  The renin-angiotensin system in the brain: possible therapeutic implications for AT1-receptor blockers , 2002, Journal of Human Hypertension.

[39]  G. Román.  Vascular dementia revisited: diagnosis, pathogenesis, treatment, and prevention. , 2002, The Medical clinics of North America.

[40]  M. Nieminen,et al.  For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group , 2022 .

[41]  A. Hofman,et al.  Antihypertensive drugs and incidence of dementia: the Rotterdam Study , 2001, Neurobiology of Aging.

[42]  S S Franklin,et al.  Predominance of Isolated Systolic Hypertension Among Middle-Aged and Elderly US Hypertensives: Analysis Based on National Health and Nutrition Examination Survey (NHANES) III , 2001, Hypertension.

[43]  A. Hofman,et al.  Blood Pressure and Risk of Dementia: Results from the Rotterdam Study and the Gothenburg H-70 Study , 2000, Dementia and Geriatric Cognitive Disorders.

[44]  S. Sidney,et al.  Short-term prognosis after emergency department diagnosis of TIA. , 2000, JAMA.

[45]  B. Davis,et al.  Effect of treating isolated systolic hypertension on the risk of developing various types and subtypes of stroke: the Systolic Hypertension in the Elderly Program (SHEP). , 2000, JAMA.

[46]  M. Kikuya,et al.  Prediction of stroke by ambulatory blood pressure monitoring versus screening blood pressure measurements in a general population: the Ohasama study , 2000, Journal of hypertension.

[47]  C. Bulpitt,et al.  Orthostatic fall in blood pressure in the very elderly hypertensive: results from the Hypertension in the Very Elderly Trial (HYVET) — pilot , 1999, Journal of Human Hypertension.

[48]  T. Hedner,et al.  Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study , 1999, The Lancet.

[49]  Karla Kerlikowske,et al.  Antihypertensive drugs in very old people: a subgroup meta-analysis of randomised controlled trials , 1999, The Lancet.

[50]  J. Tuomilehto,et al.  Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial , 1998, The Lancet.

[51]  Jan A Staessen,et al.  Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension , 1997, The Lancet.

[52]  Y. Ohgami,et al.  Transient upregulation of the AT2 receptor mRNA level after global ischemia in the rat brain , 1996, Neuropeptides.

[53]  B. Winblad,et al.  Low blood pressure and dementia in elderly people: the Kungsholmen project , 1996, BMJ.

[54]  C. Furberg,et al.  Does antihypertensive treatment of the elderly prevent cardiovascular events or prolong life? A meta-analysis of hypertension treatment trials. , 1995, Archives of family medicine.

[55]  R. Mayeux,et al.  Risk of dementia after stroke in a hospitalized cohort , 1994, Neurology.

[56]  P. Wolf,et al.  Components of Blood Pressure and Risk of Atherothrombotic Brain Infarction: The Framingham Study , 1976, Stroke.

[57]  B. Tomlinson,et al.  The Role of Angiotensin II Type 1 Receptor Antagonists in Elderly Patients with Hypertension , 2006, Drugs & aging.

[58]  V. Chair,et al.  Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the , 2006, Stroke.

[59]  C. Bulpitt,et al.  A Substudy Protocol of the Hypertension in the Very Elderly Trial Assessing Cognitive Decline and Dementia Incidence (HYVET-COG) , 2006, Drugs & aging.

[60]  George A. Mensah,et al.  The atlas of heart disease and stroke , 2005 .

[61]  P. Nilsson.  Reducing the Risk of Stroke in Elderly Patients with Hypertension , 2005, Drugs & aging.

[62]  Detection.  The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. , 1997, Archives of internal medicine.